Mechanisms of Damage to the Cardiovascular System in COVID-19

Fisun, A. Ya.; Lobzin, Yu. V.; Черкашин, Д. В.; Тыренко, В В; Tkachenko, Konstantin N.; Kachnov, V A; Kutelev, G. G.; Rudchenko, Ignat V.; Sobolev, A. V.

doi:10.15690/vramn1474

Cited by 13 publications

(3 citation statements)

References 66 publications

(75 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most patients with the symptoms of heart disease reported recent respiratory illness and confirmed COVID-19 infection caused by SARS-CoV-2 virus. Numerous studies were performed focusing on the possible mechanisms of damage to the cardiovascular system after COVID-19 [ 6 , 9 , 10 ]. However, precise pathophysiological mechanisms remain poorly understood.…”

Section: Introductionmentioning

confidence: 99%

Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center

et al. 2023

View full text Add to dashboard Cite

The aim of study was to investigate the transformative effect of the COVID-19 pandemic on magnetic resonance imaging (MRI) services in one tertiary cardiovascular center. The retrospective observational cohort study analyzed data of MRI studies (n = 8137) performed from 1 January 2019 to 1 June 2022. A total of 987 patients underwent contrast-enhanced cardiac MRI (CE-CMR). Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. The annual absolute numbers and rates of CE-CMR procedures in our center significantly increased from 2019 to 2022 (p-value < 0.05). The increasing temporal trends were observed in hypertrophic cardiomyopathy (HCMP) and myocardial fibrosis (p-value < 0.05). The CE-CMR findings of myocarditis, acute myocardial infarction, ischemic cardiomyopathy, HCMP, postinfarction cardiosclerosis, and focal myocardial fibrosis prevailed in men compared with the corresponding values in women during the pandemic (p-value < 0.05). The frequency of myocardial fibrosis occurrence increased from ~67% in 2019 to ~84% in 2022 (p-value < 0.05). The COVID-19 pandemic increased the need for MRI and CE-CMR. Patients with a history of COVID-19 had persistent and newly occurring symptoms of myocardial damage, suggesting chronic cardiac involvement consistent with long COVID-19 requiring continuous follow-up.

show abstract

Section: Introductionmentioning

confidence: 99%

Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Более чем в 25 % случаев причиной смерти этих пациентов были осложнения сердеч-но-сосудистых заболеваний (ССЗ): ОКС, декомпенсация ХСН, тромбоэмболия легочной артерии, остановка сердечной деятельности, инсульт [3,4]. Важно отметить, что сердечно-сосудистые осложнения (ССО) и по настоящее время являются одной из основных причин высокой смертности пациентов кардиологического профиля во время заболевания COVID-19, в частности из-за развития в острый период инфекции миокардита, инфаркта ОРИГИНАЛЬНЫЕ СТАТЬИ § миокарда, васкулита коронарных артерий, угрожающих жизни аритмий [5,6]. Данные патологические изменения могут возникать на фоне интерстициальной пневмонии, острого респираторного дистресс-синдрома, так называемого цитокинового шторма и / или септического шока -стигм тяжелого течения COVID-19.…”

Section: автор для перепискиunclassified

The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure

et al. 2022

View full text Add to dashboard Cite

Aim To evaluate functional changes in the heart in the long-term following COVID-19 in patients with chronic heart failure (CHF).Material and methods Case reports of 54 patients aged 69.1±9.7 years who had COVID-19 from January 2021 through January 2022 and had been previously diagnosed with NYHA functional class II-III CHF were studied. Two comparison groups were isolated: HF with LV EF >50 % (n=39) and <50 % (n=15). Echocardiography was used to evaluate changes in LV EF and pulmonary artery systolic pressure (PASP) 5-6 months following COVID-19.Results In all CHF patients after COVID-19 at 5.8 months on average, LV EF decreased (median difference, 2.5 %; 95 % confidence interval (CI): 6.99×10–5– 4.99) and PASP increased (median difference, 8 mm Hg; 95 % CI: 4.5–12.9). In the HF group with LV EF <50 %, the decrease in EF was greater than in the group with LV EF >50 % (6.9 and 0.7 %, respectively; p=0.037); furthermore, the CHF phenotype did not influence the change in PASP (p=0.4). The one-factor regression analysis showed that the dynamics of LV EF decrease was significantly influenced by the baseline decrease in LV EF, whereas the change in PASP was influenced by the dynamics of LV EF decrease, presence of dyslipidemia, and statin treatment. Furthermore, the multifactorial analysis showed that prognostically significant factors for long-term changes in LV EF following COVID-19 were male gender (odds ratio (OR), 5.92; 95 % CI: 1.31–26.75; p=0.014), LV EF at baseline <50 % (OR, 0.88; 95 % CI: 0.8–0.96; p<0.001); changes in PASP depended on the presence of dyslipidemia (OR, 0.08; 95 % CI: 0.01–0.84; p=0.018).Conclusion This study showed that COVID-19 in the long term can influence the course of CHF; in this process, HF patients with EF <50 % have progression of systolic dysfunction and PASP, whereas patients with EF >50 % have an isolated increase in PASP.

show abstract

“…Most patients reported recent respiratory illness and confirmed COVID-19 infection caused by SARS-CoV-2 virus. Numerous studies focused on the possible mechanisms of damage to the cardiovascular system after COVID-19 [6,9,10]. However, precise pathophysiological mechanisms remain poorly understood.…”

Section: Introductionmentioning

confidence: 99%

Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic

Maksimova¹,

Shelkovnikova²,

Ryumshina³

et al. 2023

Preprint

View full text Add to dashboard Cite

The aim of study was to investigate epidemiology aspects of magnetic resonance imaging (MRI) during COVID-19 pandemic. The study comprised depersonalized residents of Tomsk and Tomsk Region (n = 1714). Invitations to take online survey were sent to 50,000 residents by target SMS with response rate of 1.2% (n = 727, Cohort 1). Cohort 2 comprised retrospective patients (n = 987) who underwent contrast-enhanced cardiac MRI (CMR) in 2019-2022. Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. 29% of respondents in cohort 1 received MRI examination within past two years; 26% of respondents considered MRI the most informative imaging modality for detecting COVID-19 pneumonia; 12% of respondents reported MRI unavailable. Proportion of CMR among MRI studies increased during COVID-19 pandemic, and maximum incidence of cardiac diseases detected by MRI was in 2021. Incidence of myocardial fibrosis increased from ~67% in 2019 to ~84% in 2022. The rate of outpatient MRI studies significantly increased in 2020, but returned to pre-pandemic level in 2021. COVID-19 pandemic increased the need for MRI and CMR. Patients with history of COVID-19 had persistent and newly occurring symptoms of myocardial damage suggesting chronic cardiac involvement requiring continuous follow-up.

show abstract

Mechanisms of Damage to the Cardiovascular System in COVID-19

Cited by 13 publications

References 66 publications

Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center

Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center

The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure

Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic

Contact Info

Product

Resources

About